Encorafenib | m-entrepreneurship.com

Product Name :
Encorafenib

Search keywords :
Encorafenib

drugId :
null

Target Vo:
Serine/threonine-protein kinase B-raf

Target Vo Short Name :
B-raf

Moa_Name:
Serine/threonine-protein kinase B-raf inhibitors

First Approval Country :
United States

First Approval Date Filter:
2018

Origin Company_Name :
Novartis Pharma Ag

Active Company_Name :
Array Biopharma

Active Indication_Name:
Carcinoma, Non-Small-Cell Lung

In Active Indication_Name:
Hematologic Neoplasms

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 3 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Fas Rabbit mAb Protocol
YAP1 Rabbit mAb Technical Information
Catalase Antibody (YA811): Catalase Antibody (YA811) is a non-conjugated and Mouse origined monoclonal antibody about 60kDa, targeting to Catalase. It can be used for WB,ICC,IHC-P,FC assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts